SEARCH

SEARCH BY CITATION

References

  • 1
    Nordstrom M, Lindblad B, Bergqvist D, Kjellstrom T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med 1992; 232: 15560.
  • 2
    Coon WW. Epidemiology of venous thromboembolism. Ann Surg 1977; 186: 14964.
  • 3
    Prandoni P, Lensing AW, Cogo A, Cuppini S, Villalta S, Carta M, Cattelan AM, Polistena P, Bernardi E, Prins MH. The long-term clinical course of acute deep venous thrombosis. Ann Int Med 1996; 125: 17.
  • 4
    Bergqvist D, Jendteg S, Johansen L, Persson U, Odegaard K. Cost of long-term complications of deep venous thrombosis of the lower extremities: an analysis of a defined patient population in Sweden. Ann Int Med 1997; 126: 4547.
  • 5
    McColl MD, Ellison J, Greer IA, Tait RC, Walker ID. Prevalence of the post–thrombotic syndrome in young women with previous venous thromboembolism. Br J Haematol 2000; 108: 2724.
  • 6
    Hirsh J. Epidemiology and pathogenesis of venous thrombosis. J Am Coll Cardiol 1986; 8: 104B113B.
  • 7
    Anderson FAJ, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardhan NA, Jovanovic B, Forcier A, Dalen JE. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 1991; 151: 9338.
  • 8
    Heijboer H, Brandjes DP, Buller HR, Sturk A, Ten Cate JW. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. N Engl J Med 1990; 323: 15126.
  • 9
    Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999; 353: 116773.
  • 10
    Miletich JP. Thrombophilia as a multigenic disorder. Semin Thromb Hemost 1998; 24 (Suppl. 1): 1320.
  • 11
    Rodeghiero F, Tosetto A. Activated protein C resistance and factor V gene mutation are independent risk factors for venous thromboembolism. Ann Int Med 1999; 130: 64350.
  • 12
    Rodeghiero F, Tosetto A. The epidemiology of inherited thrombophilia: the VITA Project. Thromb Haemost 1997; 78: 63640.
  • 13
    Frezzato M, Tosetto A, Rodeghiero F. Validated questionnaire for the identification of previous personal or familial venous thromboembolism. Am J Epidemiol 1996; 143: 125765.
  • 14
    Tosetto A, Frezzato M, Rodeghiero F. Family history and inherited thrombophilia. Br J Haematol 1995; 89: 2278.
  • 15
    Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic Research. Belmont, CA: Lifetime Learning Publishers, 1982.
  • 16
    Hsieh CC. The effect of non-differential outcome misclassification on estimates of the attributable and prevented fraction. Stat Med 1991; 10: 36173.
  • 17
    Magder LS, Hughes JP. Logistic regression when the outcome is measured with uncertainty. Am J Epidemiol 1997; 146: 195203.
  • 18
    Schlesselman JJ. Case-Control Studies. New York: Oxford University Press, 1982.
  • 19
    Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: John Wiley & Sons, 1989.
  • 20
    Lachin JM. Biostatistical Methods. New York: John Wiley & Sons, 2000.
  • 21
    StataCorp. Stata Statistical Software: release 6.0. College Station Stata Corporation, 1999.
  • 22
    Anonymous. Physical status. the use and interpretation of anthropometry: report of a WHO expert committee. WHO Techn Report Series 1995; 854: 1452.
  • 23
    Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 2000; 160: 80915.
  • 24
    Hansson PO, Welin L, Tibblin G, Eriksson H. Deep vein thrombosis and pulmonary embolism in the general population: ‘the study of men born in 1913’. Arch Intern Med 1997; 157: 166570.
  • 25
    Oger E. Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Group d'Etude de la Thrombose de Bretagne Occidentale. Thromb Haemost 2000; 83: 65760.
  • 26
    Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 2000; 158: 58593.
  • 27
    Greendale GA, James MK, Espeland MA, Barrett-Connor E. Can we measure prior postmenopausal estrogen/progestin use? The Postmenopausal Estrogen/Progestin Interventions Trial. The PEPI Investigators. Am J Epidemiol 1997; 146: 76370.
  • 28
    Goodman MT, Nomura AM, Wilkens LR, Kolonel LN. Agreement between interview information and physician records on history of menopausal estrogen use. Am J Epidemiol 1990; 131: 81525.
  • 29
    Norgan NG, Cameron N. The accuracy of body weight and height recall in middle-aged men. Int J Obes Relat Metab Disord 2000; 24: 16958.
  • 30
    Must A, Willett WC, Dietz WH. Remote recall of childhood height, weight, and body build by elderly subjects. Am J Epidemiol 1993; 138: 5664.
  • 31
    Bergqvist A, Bergqvist D, Hallböök T. Deep vein thrombosis during pregnancy. Acta Obstet Gynecol Scand 1983; 62: 448.
  • 32
    McColl MD, Ramsay JE, Tait RC, Walker ID, McCall F, Conkie JA, Carty MJ, Greer IA. Risk factors for pregnancy associated venous thromboembolism. Thromb Haemost 1997; 78: 11838.
  • 33
    Lindqvist P, Dahlback B, Marsal K. Thrombotic risk during pregnancy: a population study. Obstet Gynecol 1999; 94: 5959.
  • 34
    Andersen BS, Steffensen FH, Sorensen HT, Nielsen GL, Olsen J. The cumulative incidence of venous thromboembolism during pregnancy and puerperium – an 11 year Danish population-based study of 63,300 pregnancies. Acta Obstet Gynecol Scand 1998; 77: 1703.
  • 35
    Gherman RB, Goodwin TM, Leung B, Byrne JD, Hethumumi R, Montoro M. Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy. Obstet Gynecol 1999; 94: 7304.
  • 36
    Dahl OE, Gudmundsen TE, Haukeland L. Late occurring clinical deep vein thrombosis in joint-operated patients. Acta Orthop Scand 2000; 71: 4750.
  • 37
    Sigel B, Ipsen J, Felix R. The epidemiology of lower extremity deep venous thrombosis in surgical patients. Ann Surg 1974; 179: 27890.
  • 38
    Helmerhorst FM, Bloemenkamp KW, Rosendaal FR, Vandenbroucke JP. Oral contraceptives and thrombotic disease: risk of venous thromboembolism. Thromb Haemost 1997; 78: 32733.
  • 39
    Heit JA, Mohr DN, Silverstein MD, Petterson TM, O'Fallon WM, Melton LJ. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med 2000; 160: 7618.
  • 40
    National Task Force on the Prevention and Treatment of Obesity. Overweight, obesity, and health risk. Arch Intern Med 2000; 160: 898904.